Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — Stock Valuation & Research

Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.

DMII key statistics

Price$10.21
Market cap$650.38M
SectorFinancial Services
IndustryFinancial - Conglomerates
ExchangeNASDAQ
52-week range9.86-10.33
Beta0.04

Explore DMII's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.